NCT01678274

Brief Summary

Turner syndrome is a congenital complete or partial lack one of the female sex chromosomes affecting 1 of 2000 live born girls. The syndrome is characterized by an increased prevalence of ischemic heart disease, aortic dilation and dissection, hypertension, stroke and autoimmune diseases in general. Our study aim is:

  • Using MRI to further characterize and find risk factors leading to aortic dilation.
  • Using MRI to assess the degree of aortic distensibility.
  • Using Computed tomography x-ray scanning of the heart and coronary arteries to characterize the prevalence and degree of ischemic heart disease and coronary anomalies.
  • Using pressure sensitive ultrasound (applanation tonometry) to assess the degree of aortic stiffness when compared to controls using end points as Pulse Wave Velocity, Augmentation Index and Central Pulse Pressure.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
106

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 3, 2012

Completed
1.2 years until next milestone

Study Start

First participant enrolled

December 1, 2013

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

May 24, 2016

Status Verified

June 1, 2015

Enrollment Period

2.2 years

First QC Date

August 30, 2012

Last Update Submit

May 23, 2016

Conditions

Keywords

Turner SyndromeAortic AneurysmIschemic heart diseaseHypertensionCongenital Heart DefectPulse Wave VelocityAugmentation IndexCentral Blood PressureAgatston ScoreSegment involvement score

Outcome Measures

Primary Outcomes (4)

  • Aortic dimensions

    Aortic dimensions measured by MRI

    Once

  • Agatston score

    Coronary CT evaluation of Agatston score

    Once

  • Segment involvement score

    Segment involvement score (SIS) calculated as the sum of segments with one or more coronary plaques (score 0-18).

    Once

  • Aortic distensibility

    Aortic distensibillity as measured by MRI

    Once

Secondary Outcomes (4)

  • 24 hour blood pressure

    24 hour

  • Pulse Wave Velocity

    Once

  • Augmentation index

    Once

  • Central blood pressure

    Once

Other Outcomes (1)

  • echocardiography

    Once

Study Arms (2)

Turner syndrome

Females with Turner syndrome

Control group

age matched females acting as controls

Eligibility Criteria

Age18 Years - 90 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Females with Turner Syndrome previously participating in our study number 2001024 are recruited from out-patient clinics. Controls are healthy volunteers recruited from the general population by advertisement.

You may qualify if:

  • Healthy age matched females

You may not qualify if:

  • Contraindications for MRI
  • Contraindications for CT
  • Severe obesity
  • Acute og Chronic disease with known or presumed significance with concern to outcomes of the study
  • Previous or present malignant disease
  • Clinically significant liver disease
  • Mechanic or biological heart valves

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Endocrinology and Internal medicine

Aarhus, 8000, Denmark

Location

Related Publications (4)

  • Ridder LO, Stochholm K, Mortensen KH, Andersen NH, Gravholt CH. The TGFbeta system and TIMP1 and 3 genotypes in Turner syndrome-Relation with aortic congenital malformations. Clin Endocrinol (Oxf). 2023 Dec;99(6):545-551. doi: 10.1111/cen.14907. Epub 2023 Mar 15.

  • Viuff MH, Just J, Brun S, Dam TV, Hansen M, Melgaard L, Hougaard DM, Lappe M, Gravholt CH. Women With Turner Syndrome Are Both Estrogen and Androgen Deficient: The Impact of Hormone Replacement Therapy. J Clin Endocrinol Metab. 2022 Jun 16;107(7):1983-1993. doi: 10.1210/clinem/dgac167.

  • Wen J, Trolle C, Viuff MH, Ringgaard S, Laugesen E, Gutmark EJ, Subramaniam DR, Backeljauw P, Gutmark-Little I, Andersen NH, Mortensen KH, Gravholt CH. Impaired aortic distensibility and elevated central blood pressure in Turner Syndrome: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2018 Dec 13;20(1):80. doi: 10.1186/s12968-018-0497-0.

  • Subramaniam DR, Stoddard WA, Mortensen KH, Ringgaard S, Trolle C, Gravholt CH, Gutmark EJ, Mylavarapu G, Backeljauw PF, Gutmark-Little I. Continuous measurement of aortic dimensions in Turner syndrome: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2017 Feb 24;19(1):20. doi: 10.1186/s12968-017-0336-8.

Biospecimen

Retention: SAMPLES WITH DNA

Blood Serum

MeSH Terms

Conditions

Turner SyndromeAortic AneurysmMyocardial IschemiaHypertensionHeart Defects, Congenital

Condition Hierarchy (Ancestors)

Gonadal DysgenesisDisorders of Sex DevelopmentUrogenital AbnormalitiesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesSex Chromosome Disorders of Sex DevelopmentMale Urogenital DiseasesCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSex Chromosome DisordersChromosome DisordersGenetic Diseases, InbornGonadal DisordersEndocrine System DiseasesAneurysmVascular DiseasesAortic Diseases

Study Officials

  • Claus H Gravholt, MD

    Aarhus University Hospital

    STUDY CHAIR
  • Christian Trolle, MD

    Aarhus University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 30, 2012

First Posted

September 3, 2012

Study Start

December 1, 2013

Primary Completion

March 1, 2016

Study Completion

October 1, 2016

Last Updated

May 24, 2016

Record last verified: 2015-06

Locations